Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026

Company Overview - Outset Medical, Inc. is a medical technology company focused on transforming the dialysis experience with innovative technology [4] - The company's flagship product, the Tablo® Hemodialysis System, is FDA-cleared for use in various healthcare settings, from hospitals to home care [4] - Tablo integrates water purification and on-demand dialysate production into a single system, enhancing operational efficiency and patient care [4] Financial Results Announcement - Outset Medical will release its financial results for the fourth quarter and full-year 2025 on February 11, 2026, after market close [1] - A conference call will be held on the same day at 1:30 p.m. Pacific time to discuss these results [2][3] Conference Call Details - Participants interested in the conference call must register online to receive dial-in numbers and a unique pin [3] - A live and archived webcast of the conference call will be available on the company's investor relations website [3]